CN Stock MarketDetailed Quotes

603351 Nanjing Well Pharmaceutical Group

Watchlist
  • 24.27
  • -0.27-1.10%
Market Closed May 17 15:00 CST
3.29BMarket Cap27.27P/E (TTM)

Nanjing Well Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
33.84%329.83M
4.03%1.16B
-2.62%828.68M
-11.08%522.97M
-15.19%246.45M
6.59%1.11B
11.36%850.98M
21.31%588.11M
27.77%290.59M
41.61%1.04B
Operating revenue
33.84%329.83M
4.03%1.16B
-2.62%828.68M
-11.08%522.97M
-15.19%246.45M
6.59%1.11B
11.36%850.98M
21.31%588.11M
27.77%290.59M
41.61%1.04B
Other operating revenue
----
-49.59%4.21M
----
-59.23%2.11M
----
-18.41%8.36M
----
13.73%5.18M
----
58.23%10.24M
Total operating cost
35.03%290.06M
3.23%1.04B
-2.63%744.01M
-10.05%465.64M
-16.63%214.81M
8.88%1.01B
17.12%764.1M
26.87%517.68M
34.42%257.64M
46.31%923.26M
Operating cost
41.97%244M
3.85%839.04M
0.28%602.97M
-8.27%375M
-16.06%171.87M
8.03%807.96M
14.45%601.27M
22.93%408.82M
30.92%204.75M
54.45%747.92M
Operating tax surcharges
89.77%2.23M
-3.70%7.32M
18.51%5.36M
-0.56%3M
-9.65%1.17M
10.56%7.6M
-12.37%4.52M
-3.29%3.02M
-7.12%1.3M
17.36%6.88M
Operating expense
51.07%2.88M
17.41%12.84M
-12.39%8.68M
-15.14%5.5M
-37.27%1.91M
-19.19%10.93M
17.24%9.91M
16.18%6.48M
26.96%3.04M
38.50%13.53M
Administration expense
-1.21%22.79M
-5.83%108.67M
-27.74%76.21M
-29.02%50.15M
-34.62%23.07M
8.60%115.39M
42.66%105.47M
61.44%70.65M
67.52%35.29M
18.90%106.26M
Financial expense
-37.81%2.39M
50.00%14.21M
71.98%10.22M
54.87%6.59M
58.92%3.84M
31.11%9.47M
30.51%5.94M
54.96%4.25M
160.26%2.42M
38.65%7.22M
-Interest expense (Financial expense)
2.80%3.18M
26.81%14.17M
36.79%10.87M
49.24%7.3M
48.42%3.1M
58.76%11.18M
58.71%7.95M
53.63%4.89M
52.30%2.09M
40.74%7.04M
-Interest Income (Financial expense)
-27.68%-207.01K
-24.98%-783.31K
-14.57%-534.96K
-5.74%-339.74K
-25.88%-162.13K
32.17%-626.72K
38.78%-466.95K
49.47%-321.29K
65.70%-128.8K
-20.46%-923.95K
Research and development
21.82%15.77M
3.30%55.64M
9.66%40.56M
3.88%25.41M
19.32%12.94M
29.93%53.87M
5.92%36.99M
20.63%24.46M
14.21%10.85M
13.32%41.46M
Credit Impairment Loss
-21.42%-218.99K
-101.16%-51.93K
68.43%-305.29K
86.42%-164.63K
74.54%-180.35K
290.95%4.48M
44.31%-967K
31.11%-1.21M
40.30%-708.29K
-104.10%-2.35M
Asset Impairment Loss
----
-46.11%-3.93M
-1,156.52%-1.51M
-1,156.52%-1.51M
----
-51.14%-2.69M
---120.38K
---120.38K
----
-58.21%-1.78M
Other net revenue
778,921.74%1.07M
-51.00%3.65M
-157.21%-725.94K
39.84%-728.93K
99.98%-137.14
941.84%7.44M
28.78%1.27M
-121.56%-1.21M
10.80%-855.07K
-94.85%714.44K
Fair value change income
-239.47%-47.7K
2,654.37%1.44M
107.59%95.45K
395.94%97.25K
104.94%34.2K
-96.93%52.28K
-96.87%45.98K
-105.31%-32.86K
-664.54%-691.71K
-59.88%1.7M
Invest income
----
100.06%100.03
100.06%100.03
----
----
-130.67%-166.79K
-138.95%-166.79K
-125.72%-56.07K
657.87%454.95K
-92.96%543.77K
Asset deal income
----
----
----
----
----
96.50%-1.87K
----
----
----
---53.38K
Other revenue
814.16%1.33M
7.37%6.19M
-59.78%996.35K
305.27%851K
62.27%146.01K
117.56%5.77M
182.83%2.48M
-44.12%209.98K
-65.16%89.98K
-36.47%2.65M
Operating profit
29.09%40.84M
7.55%121.78M
-4.76%83.95M
-18.24%56.6M
-1.41%31.64M
-5.45%113.23M
-21.86%88.14M
-9.15%69.22M
-7.78%32.09M
0.71%119.76M
Add:Non operating Income
----
49.03%18.87K
70.59%18.87K
70.59%18.87K
----
-75.82%12.66K
-78.88%11.06K
11,185.77%11.06K
----
-87.47%52.36K
Less:Non operating expense
-68.19%11.68K
-9.57%354.16K
31.46%170.2K
60.21%149.82K
-19.39%36.72K
-63.53%391.62K
-73.34%129.47K
-53.47%93.52K
-50.49%45.55K
2.34%1.07M
Total profit
29.20%40.83M
7.61%121.44M
-4.80%83.8M
-18.33%56.47M
-1.38%31.6M
-4.96%112.85M
-21.66%88.02M
-9.02%69.14M
-7.67%32.04M
0.38%118.74M
Less:Income tax cost
22.60%7.31M
-33.07%12.33M
-27.46%7.82M
-51.81%4.5M
12.95%5.97M
-0.90%18.42M
-62.81%10.78M
-52.13%9.33M
-37.84%5.28M
4.21%18.59M
Net profit
30.74%33.52M
15.55%109.11M
-1.64%75.98M
-13.10%51.97M
-4.21%25.64M
-5.71%94.43M
-7.36%77.25M
5.86%59.81M
2.11%26.76M
-0.30%100.15M
Net profit from continuing operation
30.74%33.52M
15.55%109.11M
-1.64%75.98M
-13.10%51.97M
-4.21%25.64M
-5.71%94.43M
-7.36%77.25M
5.86%59.81M
2.11%26.76M
-0.30%100.15M
Less:Minority Profit
-61.06%-1.09M
-417.02%-3.08M
-75.82%-2.29M
-48.10%-1.42M
11.94%-674.99K
51.15%-596.62K
-185.27%-1.3M
---955.91K
---766.52K
---1.22M
Net profit of parent company owners
31.52%34.6M
18.07%112.2M
-0.36%78.27M
-12.14%53.39M
-4.43%26.31M
-6.26%95.03M
-6.31%78.55M
7.55%60.76M
5.04%27.53M
0.92%101.37M
Earning per share
Basic earning per share
30.00%0.26
15.28%0.83
-1.69%0.58
-13.33%0.39
-4.76%0.2
-5.26%0.72
-7.81%0.59
4.65%0.45
5.00%0.21
-1.30%0.76
Diluted earning per share
30.00%0.26
16.90%0.83
-1.69%0.58
-13.33%0.39
-4.76%0.2
-6.58%0.71
-7.81%0.59
4.65%0.45
5.00%0.21
-1.30%0.76
Other composite income
Total composite income
30.74%33.52M
15.55%109.11M
-1.64%75.98M
-13.10%51.97M
-4.21%25.64M
-5.71%94.43M
-7.36%77.25M
5.86%59.81M
2.11%26.76M
-0.30%100.15M
Total composite income of parent company owners
31.52%34.6M
18.07%112.2M
-0.36%78.27M
-12.14%53.39M
-4.43%26.31M
-6.26%95.03M
-6.31%78.55M
7.55%60.76M
5.04%27.53M
0.92%101.37M
Total composite income of minority owners
-61.06%-1.09M
-417.02%-3.08M
-75.82%-2.29M
-48.10%-1.42M
11.94%-674.99K
51.15%-596.62K
-185.27%-1.3M
---955.91K
---766.52K
---1.22M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 33.84%329.83M4.03%1.16B-2.62%828.68M-11.08%522.97M-15.19%246.45M6.59%1.11B11.36%850.98M21.31%588.11M27.77%290.59M41.61%1.04B
Operating revenue 33.84%329.83M4.03%1.16B-2.62%828.68M-11.08%522.97M-15.19%246.45M6.59%1.11B11.36%850.98M21.31%588.11M27.77%290.59M41.61%1.04B
Other operating revenue -----49.59%4.21M-----59.23%2.11M-----18.41%8.36M----13.73%5.18M----58.23%10.24M
Total operating cost 35.03%290.06M3.23%1.04B-2.63%744.01M-10.05%465.64M-16.63%214.81M8.88%1.01B17.12%764.1M26.87%517.68M34.42%257.64M46.31%923.26M
Operating cost 41.97%244M3.85%839.04M0.28%602.97M-8.27%375M-16.06%171.87M8.03%807.96M14.45%601.27M22.93%408.82M30.92%204.75M54.45%747.92M
Operating tax surcharges 89.77%2.23M-3.70%7.32M18.51%5.36M-0.56%3M-9.65%1.17M10.56%7.6M-12.37%4.52M-3.29%3.02M-7.12%1.3M17.36%6.88M
Operating expense 51.07%2.88M17.41%12.84M-12.39%8.68M-15.14%5.5M-37.27%1.91M-19.19%10.93M17.24%9.91M16.18%6.48M26.96%3.04M38.50%13.53M
Administration expense -1.21%22.79M-5.83%108.67M-27.74%76.21M-29.02%50.15M-34.62%23.07M8.60%115.39M42.66%105.47M61.44%70.65M67.52%35.29M18.90%106.26M
Financial expense -37.81%2.39M50.00%14.21M71.98%10.22M54.87%6.59M58.92%3.84M31.11%9.47M30.51%5.94M54.96%4.25M160.26%2.42M38.65%7.22M
-Interest expense (Financial expense) 2.80%3.18M26.81%14.17M36.79%10.87M49.24%7.3M48.42%3.1M58.76%11.18M58.71%7.95M53.63%4.89M52.30%2.09M40.74%7.04M
-Interest Income (Financial expense) -27.68%-207.01K-24.98%-783.31K-14.57%-534.96K-5.74%-339.74K-25.88%-162.13K32.17%-626.72K38.78%-466.95K49.47%-321.29K65.70%-128.8K-20.46%-923.95K
Research and development 21.82%15.77M3.30%55.64M9.66%40.56M3.88%25.41M19.32%12.94M29.93%53.87M5.92%36.99M20.63%24.46M14.21%10.85M13.32%41.46M
Credit Impairment Loss -21.42%-218.99K-101.16%-51.93K68.43%-305.29K86.42%-164.63K74.54%-180.35K290.95%4.48M44.31%-967K31.11%-1.21M40.30%-708.29K-104.10%-2.35M
Asset Impairment Loss -----46.11%-3.93M-1,156.52%-1.51M-1,156.52%-1.51M-----51.14%-2.69M---120.38K---120.38K-----58.21%-1.78M
Other net revenue 778,921.74%1.07M-51.00%3.65M-157.21%-725.94K39.84%-728.93K99.98%-137.14941.84%7.44M28.78%1.27M-121.56%-1.21M10.80%-855.07K-94.85%714.44K
Fair value change income -239.47%-47.7K2,654.37%1.44M107.59%95.45K395.94%97.25K104.94%34.2K-96.93%52.28K-96.87%45.98K-105.31%-32.86K-664.54%-691.71K-59.88%1.7M
Invest income ----100.06%100.03100.06%100.03---------130.67%-166.79K-138.95%-166.79K-125.72%-56.07K657.87%454.95K-92.96%543.77K
Asset deal income --------------------96.50%-1.87K---------------53.38K
Other revenue 814.16%1.33M7.37%6.19M-59.78%996.35K305.27%851K62.27%146.01K117.56%5.77M182.83%2.48M-44.12%209.98K-65.16%89.98K-36.47%2.65M
Operating profit 29.09%40.84M7.55%121.78M-4.76%83.95M-18.24%56.6M-1.41%31.64M-5.45%113.23M-21.86%88.14M-9.15%69.22M-7.78%32.09M0.71%119.76M
Add:Non operating Income ----49.03%18.87K70.59%18.87K70.59%18.87K-----75.82%12.66K-78.88%11.06K11,185.77%11.06K-----87.47%52.36K
Less:Non operating expense -68.19%11.68K-9.57%354.16K31.46%170.2K60.21%149.82K-19.39%36.72K-63.53%391.62K-73.34%129.47K-53.47%93.52K-50.49%45.55K2.34%1.07M
Total profit 29.20%40.83M7.61%121.44M-4.80%83.8M-18.33%56.47M-1.38%31.6M-4.96%112.85M-21.66%88.02M-9.02%69.14M-7.67%32.04M0.38%118.74M
Less:Income tax cost 22.60%7.31M-33.07%12.33M-27.46%7.82M-51.81%4.5M12.95%5.97M-0.90%18.42M-62.81%10.78M-52.13%9.33M-37.84%5.28M4.21%18.59M
Net profit 30.74%33.52M15.55%109.11M-1.64%75.98M-13.10%51.97M-4.21%25.64M-5.71%94.43M-7.36%77.25M5.86%59.81M2.11%26.76M-0.30%100.15M
Net profit from continuing operation 30.74%33.52M15.55%109.11M-1.64%75.98M-13.10%51.97M-4.21%25.64M-5.71%94.43M-7.36%77.25M5.86%59.81M2.11%26.76M-0.30%100.15M
Less:Minority Profit -61.06%-1.09M-417.02%-3.08M-75.82%-2.29M-48.10%-1.42M11.94%-674.99K51.15%-596.62K-185.27%-1.3M---955.91K---766.52K---1.22M
Net profit of parent company owners 31.52%34.6M18.07%112.2M-0.36%78.27M-12.14%53.39M-4.43%26.31M-6.26%95.03M-6.31%78.55M7.55%60.76M5.04%27.53M0.92%101.37M
Earning per share
Basic earning per share 30.00%0.2615.28%0.83-1.69%0.58-13.33%0.39-4.76%0.2-5.26%0.72-7.81%0.594.65%0.455.00%0.21-1.30%0.76
Diluted earning per share 30.00%0.2616.90%0.83-1.69%0.58-13.33%0.39-4.76%0.2-6.58%0.71-7.81%0.594.65%0.455.00%0.21-1.30%0.76
Other composite income
Total composite income 30.74%33.52M15.55%109.11M-1.64%75.98M-13.10%51.97M-4.21%25.64M-5.71%94.43M-7.36%77.25M5.86%59.81M2.11%26.76M-0.30%100.15M
Total composite income of parent company owners 31.52%34.6M18.07%112.2M-0.36%78.27M-12.14%53.39M-4.43%26.31M-6.26%95.03M-6.31%78.55M7.55%60.76M5.04%27.53M0.92%101.37M
Total composite income of minority owners -61.06%-1.09M-417.02%-3.08M-75.82%-2.29M-48.10%-1.42M11.94%-674.99K51.15%-596.62K-185.27%-1.3M---955.91K---766.52K---1.22M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg